Measuring disability progression in MS.
Measuring disability progression in MS.
Measuring disability progression in MS.
Glatiramer acetate in primary progressive multiple sclerosis:
Improvements in muscle-tendon properties are beneficial to balance in MS.
Naltrexone
(nal trex’ one)
From:
SafeMedication.com
Other Names:ReVia
Important Warning
Large doses of naltrexone may cause liver failure. Tell your doctor if you have liver or kidney disease. If you experience the following symptoms, stop taking naltrexone and call your doctor immediately: excessive tiredness, unusual bleeding or bruising, loss of appetite, pain in the upper right part of your stomach, dark urine, or yellowing of the skin or eyes.
Why is this medication
A comparison of interferon beta therapies for RRMS.
Dept. of Neurology,
Cologne City Hospitals,
University of Colognen, Ostmerheimerstr. 200, 51109,
Cologne, Germany
Interferon beta preparations are the most frequently prescribed therapies for patients with relapsing MS (MS). There are three different kinds of Interferon beta medications… read more »
Patient Advocates With MS Fund Clinical Trial Of
Promising Drug That Has Already Helped Thousands
Over the last decade, anecdotal reports suggested that a very low
dose of an FDA-approved (in the United States) drug called naltrexone provides effective symptom relief for many patients who suffer from Multiple Sclerosis.
Frustrated by the lack of scientific research, volunteers began
raising money to fund a human clinical trial… read more »
MS: Extent of Brain Involvement at Diagnosis May Predict Later Brain
Atrophy
CHICAGO, IL — February 13, 2007 — In patients with recently
diagnosed multiple sclerosis, the extent of accumulated brain tissue
loss and overall lesion load as determined by magnetic resonance
imaging (MRI) may predict the rate of cerebral atrophy over the
following two years. That’s according to a report in the February
issue of Archives of Neurology.
MRI is used to… read more »
Doctors often speak of the “natural history” of MS – the usual course of the disease. Does biology dictate your destiny or can the future be changed? The editor of the latest msdialogue® explores the question: will treatment improve your prospects down the road?
This magazine entitled “What Does the Future hold?” is available on the MSWatch.ca website. This magazine can be accessed by clicking on the MSUniversity® tab. Then, click… read more »
vitamin B-12 and depression
Doctors have long known of the relationship between low levels of vitamin B-12 and depression. Vitamin B-12 and other B vitamins, such as folate
SRI to Evaluate Drug for Treatment of Multiple Sclerosis and Other Disorders Such as Rheumatoid Arthritis and Atherosclerosis